CARES:A Prospective, Phase IV, Open-Label, Non-Randomiozed, Multicenter, Surveillance REgistry Study to Evaluate the Safety of DEFINITY in Clinical Practice

ID Number 08-1284

Principal Investigator(s)
Martin E Goldman

Department(s) or Division(s)
Cardiology

Research Entity
Zena and Michael A. Wiener Cardiovascular Institute

Description

The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®. DEFINITY is a contrast agent that is used during echocardiogram measurements of the heart. ClinicalTrials.gov Identifier: NCT00625365



Contact Information
Ida Guzman
Ida.Guzman@mountsinai.org


Recruiting Patients: No